Atnaujinta: 2024.11.26 04:01 (GMT+2)

Tallinna Farmaatsiatehas: Balance sheet 30.06.2000

2000.08.30, Tallinna Farmaatsiatehas, TLN
TALLINNA FARMAATSIATEHAS
BALANCE SHEET

BALANCE SHEET 30.06.2000

thousand EEK 30.06.2000 31.12.1999

A S S E T S

CURRENT ASSETS
Cash and bank accounts 922 1 782
Customer receivables
ACCOUNTS RECEIVABLE 2 021 3 443
ALLOWANCE FOR DOUBTFUL RECEIVABLES
RESERV -462 -
Total 1 559 3 443

Other receivables
RECEIVABLES FROM PARENT COMPANY 22 965 22 601
OTHER SHORT-TERM RECEIVABLES 1 602 3 048
Total 24 566 25 649

Accrued income 37 37
Prepaid expenses 359 473
Inventories
RAW MATERIAL 11 872 12 380
WORK-IN-PROGRESS 770 879
FINISHED GOODS 19 073 12 415
PREPAYMENTS TO SUPPLIERS 182 1 266
Total 31 898 26 940

TOTAL CURRENT ASSETS 59 342 58 324

NON-CURRENT ASSETS
Long-term investments 482 480

Fixed assets
FIXED ASSETS IN NET BOOK VALUE 31 629 33 561
CONSTRUCTION IN PROGRESS 2 128 1 344
Total 33 757 34 905

Intangible assets 2 688 3 218

TOTAL NON-CURRENT ASSETS 36 927 38 604

TOTAL ASSETS 96 269 96 928



LIABILITIES AND SHAREHOLDERS’ EQUITY

LIABILITIES
CURRENT LIABILITIES
CURRENT PORTION OF LONG-TERM DEBT 3 852 7 703
SHORT-TERM BANK LOANS - 418
Total 3 852 8 121

Customers prepayments - 44
Accounts payable 14 162 13 130
Other payables 509 1 006
Taxes payable 1 316 1 575
Accrued expenses 1 552 1 969

TOTAL CURRENT LIABILITIES 21 390 25 846

NON-CURRENT LIABILITIES
Long-term debt obligations
BANK LOANS 30 812 30 812
PAYABLES TO PARENT COMPANY 28 232 28 232
TOTAL NON-CURRENT LIABILITIES 59 044 59 044
TOTAL LIABILITIES 80 434 84 890

SHAREHOLDERS’ EQUITY
SHARE CAPITAL 12 500 12 500
RESERVES 2 316 2 316
RETAINED EARNINGS
(ACCUMULATED DEFICIT) -2 779 -8 560
PROFIT (LOSS) FOR FINANCIAL YEAR 3 796 5 782
SHAREHOLDERS’ EQUITY TOTAL 15 834 12 037

LIABILITIES AND SHAREHOLDERS’ EQUITY 96 269 96 928


Raivo Unt
Financial Director
+372 6120201

Vertybiniai popieriai

Akcijos
Obligacijos
Fondai

Rinkos informacija

Statistika
Prekyba
Indeksai
Aukcionai

Reguliavimas

Taisyklės ir nuostatos
Priežiūra

Kaip pradėti

Įmonėms
Investuotojams
Nariams
First North sertifikuotiems PATARĖJAMS

Naujienos

Nasdaq naujienos
Emitento naujienos
Kalendorius

Apie mus

Nasdaq Baltijos rinkoje
Biurai